Use of Taxus polymer-coated paclitaxel-eluting stents for treatment of in-stent restenosis in real world patients: Results of clinical and angiographic follow-up at six months in a single-center registry

Catheterization and Cardiovascular Interventions

Volumn 68, Issue 3, 2006, Pages 343-348

  Lim, Victor Y ^a   Buellesfeld, Lutz ^a   Gerckens, Ulrich ^a   Mueller, Ralf ^a   Schmidt, Thomas ^a   Grube, Eberhard ^a  

^a Heart Center Siegburg   (Germany)

Author keywords

Neointimal formation; Percutaneous coronary intervention; Revascularization; Stents

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; INTIMA; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; BLOOD VESSEL PROSTHESIS IMPLANTATION; CARDIOVASCULAR AGENTS; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; EQUIPMENT SAFETY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; POLYMERS; PROSPECTIVE STUDIES; STENTS; SURVIVAL RATE; TAXUS; TREATMENT OUTCOME;

EID: 33748296091     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.20785     Document Type: Article

References (25)

1. Morice MC, Serruys PW, Sousa JE, et al. RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-1780.
2. Fajadet J, Morice MC, Bode C, et al. Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: Three-year results of the RAVEL trial. Circulation 2005;111:1040-1044.
3. Moses JW, Leon MB, Popma JJ, et al. SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
4. Holmes DR Jr, Leon MB, Moses JW, et al. Analysis of 1-year clinical outcomes in the SIRIUS trial. A randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation 2004;109:634-640.
5. Schofer J, Schluter M, Gershlick AH, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: Double-blind, randomised controlled trial (E-SIRIUS). Lancet 2003;362:1093-1099.
6. Schampaert E, Cohen EA, Schluter M, et al. C-SIRIUS Investigators. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 2004;43:1110-1115.
7. Grube E, Silber S, Hauptmann KE, et al. TAXUS I: Six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 2003;107:38-42.
8. Colombo A, Drzewiecki J, Banning A, et al. TAXUS II Study Group. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003;108:788-794.
9. Stone GW, Ellis SG, Cox DA, et al. TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-231.
10. Stone GW, Ellis SG, Cox DA, et al. TAXUS-IV Investigators. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent. The TAXUS-IV trial. Circulation 2004;109:1942.
11. Waksman R, White RL, Chan RC, et al. Intracoronary γ-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation 2000;101:2165-2171.
12. Ajani A, Kim H-S, Waksman R. Clinical trials of vascular brachytherapy for in-stent restenosis: Update. Cardiovasc Radiat Med 2001;2:107-113.
13. Grise MA, Massullo V, Jani S, et al. Five-year clinical follow-up after intracoronary radiation. Results of a randomized clinical trial. Circulation 2002;105:2737-2740.
14. Leon MB. 5-year clinical results of the γ-1 trial. Presented at the Transcatheter Cardiovascular Therapeutics Meeting, Washington, DC, 27 Sept-1 Oct 2004.
15. Costa MA, Sabate M, van der Giessen WJ, et al. Late coronary occlusion after intracoronary brachytherapy. Circulation 1999;100:789-792.
16. Mehran R, Dangas G, Abizaid AS, et al. Angiographic patterns of in-stent restenosis. Classification and implications for long-term outcome. Circulation 1999;100:1872-1878.
17. Lowe HC, Oesterle SN, Khachigian LM. Coronary in-stent restenosis: Current status and future strategies. J Am Coll Cardiol 2002;39:183-193.
18. Neumann FJ, Desmet W, Grube E, et al. Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement. Circulation 2005;111:2107-2111.
19. Saia F, Lemos PA, Arampatzis CA, et al. Routine sirolimus eluting stent implantation for unselected in-stent restenosis: Insights from the rapamycin eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. Heart 2004;90:1183-1188.
20. Tanabe K, Serruys PW, Grube E, et al. TAXUS III Trial: In-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation 2003;107:559-564.
21. Hoffmann R, Langenberg R, Radke P, et al. Treatment of in-stent restenosis using a stent with non-polymer-based paclitaxel elution. Am J Cardiol 2004;93:760-762.
22. Adamian M, Colombo A, Briguori C, et al. Cutting balloon angioplasty for the treatment of in-stent restenosis: A matched comparison with rotational atherectomy, additional stent implantation and balloon angioplasty. J Am Coll Cardiol 2001;38:672-679.
23. Elezi S, Kastrati A, Hadamitzky M, et al. Clinical and angiographic follow-up after balloon angioplasty with provisional stenting for coronary in-stent restenosis. Catheter Cardiovasc Interv 1999;48:151-156.
24. Alfonso F, Cequier A, Zueco J, et al. Stenting the stent: Initial results and long-term clinical and angiographic outcome of coronary stenting for patients with in-stent restenosis. Am J Cardiol 2000;85:327-332.
25. Kastrati A, Mehilli J, von Beckerath N, et al. ISAR-DESIRE Study Investigators. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: A randomized controlled trial. JAMA 2005;293:165-171.